Used primarily in pharmaceutical research as a kinase inhibitor, particularly targeting proteins involved in cell signaling pathways. Shows potential in oncology for inhibiting tumor growth by interfering with key enzymatic activities that drive cancer progression. Also serves as a building block in the synthesis of more complex bioactive molecules. Its structure allows for selective interaction with ATP-binding sites in kinases, making it valuable in the development of targeted therapies. Investigated for use in treatments involving inflammatory diseases and neurological disorders due to its ability to modulate specific cellular responses.